The cytochrome P450C17 (C17) is the steroidogenic enzyme responsible for th
e conversion of pregnenolone and progesterone to dehydroepiandrosterone (DH
EA) and Delta (4)-androstenedione (AD) respectively. This conversion is ach
ieved by two enzymatic activities, 17 alpha -hydroxylase and 17,20-lyase, l
ocated at the same active site. In man, the adrenal C17 basically only prod
uces DHEA. We have shown that the hamster adrenal C17 produces DHEA as well
as AD. Moreover, the hamster like man produces cortisol as its major gluco
corticoid. We can thus compare the hamster and human adrenal C17, and use t
heir differences in order to elaborate a strategy for structure-function st
udies. We have thus engineered hamster adrenal C17 mutants which possess mo
dified enzymatic activities. We also proceeded to elaborate a three-dimensi
onal model of the hamster C17 to visualise the structural impact of these m
utations. This model demonstrates that the mutations created are not locali
sed at the active site, but rather in surrounding regions. These could affe
ct the conformation of the active site, in turn, modulating the 17 alpha -h
ydroxylase and 17,20-lyase activities. For example, the mutation T202N is l
ocated next to Val 482 and Val 483 which compose the roof of the active sit
e. This mutation decreased both 17 alpha -hydroxylase and 17,20-lyase activ
ities, indicating the importance of the roof of the active site for general
functionality of the C17.